Skip Navigation LinksHome > June 2013 - Volume 23 - Issue 5 > Treatment Patterns, Health Care Utilization, and Costs of Ov...
International Journal of Gynecological Cancer:
doi: 10.1097/IGC.0b013e318291e8ca
Ovarian Cancer

Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

Kim, Kun MSc*; Hernlund, Emma PhD*; Hernadi, Zoltán MD; Révész, János MD; Pete, Imre PhD, MD§; Szánthó, András PhD, MD; Bodnar, Lubomir MD; Madry, Rodoslaw MD#; Timorek–Lemieszczuk, Agnieszka PhD, MD**; Bozanovic, Tatjana MD††; Vasovic, Suzana MD‡‡; Tomasevic, Zorica PhD, MD‡‡; Zivaljevic, Milica MD§§; Pazin, Vladimir MD∥∥; Minárik, Tomáš PhD, MD¶¶; Garanová, Hana MD##; Heľpianska, Lýdia MD***; Justo, Nahila MBA, MSc*

Supplemental Author Material
Collapse Box

Abstract

Objective: Despite the considerable disease burden of ovarian cancer, there were no cost studies in Central and Eastern Europe. This study aimed to describe treatment patterns, health care utilization, and costs associated with treating ovarian cancer in Hungary, Poland, Serbia, and Slovakia.

Method: Overall clinical practice for management of epithelial ovarian cancer was investigated through a 3-round Delphi panel. Experts completed a survey based on the chart review (n = 1542). The survey was developed based on clinical guidelines and the International Federation of Gynecology and Obstetrics Annual Report. Means, ranges, and outlier values were discussed with the experts during a telephone interview. Finally, consensus estimates were obtained in face-to-face workshops. Based on these results, overall cost of ovarian cancer was estimated using a Markov model.

Results: The patients included in the chart review were followed up from presurgical diagnosis and in each phase of treatment, that is, surgical staging and primary surgery, chemotherapy and chemotherapy monitoring, follow-up, and palliative care. The 5-year overall cost per patient was €14,100 to €16,300 in Hungary, €14,600 to €15,800 in Poland, €7600 to €8100 in Serbia, and €12,400 to €14,500 in Slovakia. The main components were chemotherapy-associated costs (68%–74% of the total cost), followed by cost of primary treatment with surgery (15%–21%) and palliative care (3%–10%).

Conclusions: Patients with ovarian cancer consume considerable health care resources and incur substantial costs in Central and Eastern Europe. These findings may prove useful for clinicians and decision makers in understanding the economic implications of managing ovarian cancer in Central and Eastern Europe and the need for innovative therapies.

Copyright © 2013 by IGCS and ESGO

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/IJGConline

For additional oncology content, visit LWW Oncology Journals on Facebook.